illustration of new coronavirus 2019-nCoV

Image source: Centers for Disease Control and Prevention (CDC)/Alissa Eckert, MS

News • Genomic insights into 2019-nCoV

New coronavirus: largest meta-analysis yet answers important questions

Scientists at the University of Bologna have conducted the largest analysis of coronavirus 2019-nCoV genomes sequenced so far.

This analysis confirms that the virus originates in bats and shows a low variability: the virus heterogeneity is low. At the same time, researchers identified a hyper-variable genomic hotspot in the proteins of the virus responsible for the existence of two virus subtypes.

Click to enlarge: Phylogenetic tree of all the 2019-nCov sequences available at 02-Feb-2020 (branches shown in blue), plus six Bat coronavirus sequences (default black, as they are split in multiple taxa), six Human SARS (green) and 2 MERS (orange). The percentage of bootstraps supporting each branch is reported. Branches corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed.

Image source: University of Bologna/Ceraolo et al. 2020; Journal of Medical Virology

Leading author of this study, published on the Journal of Medical Virology, is Federico M. Giorgi, bioinformatics researcher at the Department of Pharmacy and Biotechnology of the University of Bologna.

The data released by the World Health Organization reveal that, to date, the coronavirus 2019-nCoV has infected 28,276 people, of whom 565 died. This new study analysed the genomes of the 56 coronavirus strains sequenced in different parts of the world, including those extracted from the two Chinese patients held at the Infectious Disease Ward of Lazzaro Spallanzani Hospital in Rome, Italy. This is the most comprehensive study about coronavirus genomes so far conducted.

Researchers confirmed the notion that the virus probably originates from a zoonotic pathogen: the virus closest relative, that was isolated in the past few weeks, matches the coronavirus sequence EPI_ISL_402131 found in the Rhinolophus affinis, a medium-size Asian bat of the Yunnan Province (China). The human coronavirus genome shares at least 96.2% of its identity with its bat relative, while its similarity rate with the human strain of the SARS virus (Severe Acute Respiratory Syndrome) is much lower, only 80.3%.

With a homogeneous viral population, potential drug therapies are deemed to be more effective on everyone

Federico M. Giorgi

Researchers have also discovered that all the existing DNA sequences of coronavirus are very similar, even if they come from different regions of China and from various parts of the world: the genomes obtained from patients since the beginning of the outbreak share a sequence identity that goes over 99%. "The virus shows low heterogeneity and variability: this is good news", explains Federico M. Giorgi. "With a homogeneous viral population, potential drug therapies are deemed to be more effective on everyone".

However, the study identified for the first time a hyper-variable hotspot in the virus proteins, eventually pinpointing two virus subtypes. The latter differ only by a single amino acid, which is able to change the sequence and the structure of ORF8-encoded protein, a virus component yet to be characterized.

Source: University of Bologna


Related articles


News • COVID-19 infections

Genetic network analysis provides 'snapshot' of pandemic origins

Researchers from Cambridge, UK, and Germany have reconstructed the early “evolutionary paths” of COVID-19 in humans – as infection spread from Wuhan out to Europe and North America – using…


News • Preparing for the next pandemic

New rapid electronic diagnostic test for infectious diseases

A new molecular test for bacteria and viruses, including Sars-CoV-2, has been developed at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.


News • Diagnosis done quick

New sensor tells apart Covid-19 and flu infections - in 10 seconds

US scientists report using a single-atom-thick nanomaterial to simultaneously detect Covid-19 and flu viruses — at much lower levels and much more quickly than conventional tests for either.

Related products

Subscribe to Newsletter